People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aulos Bioscience, Inc. | — | Biotechnology | Series A | $20.0M | $41.1M | 2020 |
| Aethon Therapeutics, Inc. | — | Biotechnology | Series A | $6.0M | $66.3M | 2022 |
Rajesh Chopra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rajesh Chopra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 2 | 19 |
| Michael Ehlers | 1 | 6 |
| Paul Da Silva Jardine | 1 | 3 |
| Yechezkel Barenholz | 1 | 3 |
| Joseph Yanchik | 1 | 3 |
| Anna Batarina | 1 | 2 |
| Yanay Ofran | 1 | 2 |
| Leo J. Redmond | 1 | 1 |
| Micah Pearlman | 1 | 1 |
| William Engels | 1 | 1 |
| James J. Vasselli | 1 | 1 |
| Aron Knickerbocker | 1 | 1 |
| Mace Rothenberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.